101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease

TEL AVIV, Israel & ENGLEWOOD, N.J.--(BUSINESS WIRE)--101 Therapeutics releases evidence package for 101-PGC-005, seeking independent review for therapeutic use in Bundibugyo Ebola crisis.